BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35536438)

  • 21. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
    Adewumi OM; Dukhovlinova E; Shehu NY; Zhou S; Council OD; Akanbi MO; Taiwo B; Ogunniyi A; Robertson K; Kanyama C; Hosseinipour MC; Swanstrom R
    AIDS Res Hum Retroviruses; 2020 Jun; 36(6):490-500. PubMed ID: 31914800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.
    St Bernard L; Abolade J; Mohri H; Markowitz M; Evering TH
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
    AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
    Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA;
    J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse of Symptomatic Cerebrospinal Fluid HIV Escape.
    Ferretti F; De Zan V; Gerevini S; Turrini F; Boeri E; Gianotti N; Hasson H; Lazzarin A; Cinque P
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):522-528. PubMed ID: 32875516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the Central Nervous System Reservoir a Hurdle for an HIV Cure?
    Mohammadzadeh N; Chomont N; Estaquier J; Cohen EA; Power C
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The capacity of HIV in the blood and the cerebrospinal fluid depending on antiretroviral drugs.
    Boiko YI; Moskaliuk VD; Randuk YO; Balaniuk IV; Rudan IV; Kolotylo TR; Melenko SR
    J Med Life; 2022 May; 15(5):620-624. PubMed ID: 35815088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
    Sharma V; Creegan M; Tokarev A; Hsu D; Slike BM; Sacdalan C; Chan P; Spudich S; Ananworanich J; Eller MA; Krebs SJ; Vasan S; Bolton DL;
    PLoS Pathog; 2021 Dec; 17(12):e1010105. PubMed ID: 34874976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.
    Schnell G; Price RW; Swanstrom R; Spudich S
    J Virol; 2010 Mar; 84(5):2395-407. PubMed ID: 20015984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous system.
    Almeida SM
    Arq Neuropsiquiatr; 2015 Jul; 73(7):624-9. PubMed ID: 26200059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
    Cinque P; Bestetti A; Morelli P; Presi S
    J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
    Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
    Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
    PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
    Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
    Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    Burbelo PD; Price RW; Hagberg L; Hatano H; Spudich S; Deeks SG; Gisslén M
    J Infect Dis; 2018 Mar; 217(7):1024-1032. PubMed ID: 29401308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.
    Kincer LP; Joseph SB; Gilleece MM; Hauser BM; Sizemore S; Zhou S; Di Germanio C; Zetterberg H; Fuchs D; Deeks SG; Spudich S; Gisslen M; Price RW; Swanstrom R
    Nat Microbiol; 2023 Feb; 8(2):260-271. PubMed ID: 36717718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.
    Antinori A; Giancola ML; Grisetti S; Soldani F; Alba L; Liuzzi G; Amendola A; Capobianchi M; Tozzi V; Perno CF
    AIDS; 2002 Sep; 16(14):1867-76. PubMed ID: 12351946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection.
    Spatola M; Loos C; Cizmeci D; Webb N; Gorman MJ; Rossignol E; Shin S; Yuan D; Fontana L; Mukerji SS; Lauffenburger DA; Gabuzda D; Alter G
    J Infect Dis; 2022 Sep; 226(4):738-750. PubMed ID: 35417540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
    Edén A; Fuchs D; Hagberg L; Nilsson S; Spudich S; Svennerholm B; Price RW; Gisslén M
    J Infect Dis; 2010 Dec; 202(12):1819-25. PubMed ID: 21050119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare case of HIV CNS escape in a patient previously considered a viral controller.
    Magid-Bernstein J; Guo CY; Chow FC; Thakur KT
    Int J STD AIDS; 2020 Jun; 31(7):694-698. PubMed ID: 32538333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.